Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
Researchers have developed a new AI system that improves lung cancer detection by analysing CT scans at both microscopic and ...
A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...
Discover how a new nanophotonic chip uses genetic markers and AI to detect diseases in minutes, potentially revolutionising ...
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
Startup SpotitEarly is pioneering an innovative early cancer screening test based on breath samples and powered by artificial intelligence and the strong scent detection of trained dogs. SpotitEarly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results